Infusions
Latest
The Research Behind Remdesivir
How a twice-shelved drug became the standard of care for the most widespread disease
1291d
Supplies Still Limited More Than a Year After Monoclonal Antibodies Authorized for Treating COVID-19
Despite being the only authorized outpatient medical therapy for preventing the worsening of COVID-19 symptoms in high-risk patients, there remains no steady supply of monoclonal antibodies from the federal government ...
1613d
Results for COVID-19 Convalescent Plasma Still Inconclusive More Than a Year After Emergency Authorization Issued
News Analysis Data on the effectiveness of convalescent plasma for hospitalized COVID-19 patients is still inconclusive despite more than a year since the federal authority first issued an emergency use ...
1717d